These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 15840033)

  • 21. [Vasopressin receptor antagonists: the vaptans].
    Villabona C
    Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance.
    Decaux G; Namias B; Gulbis B; Soupart A
    J Am Soc Nephrol; 1996 May; 7(5):805-10. PubMed ID: 8738818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.
    Zhu X; Huang Y; Li S; Ge N; Li T; Wang Y; Liu K; Liu C
    J Am Heart Assoc; 2020 May; 9(10):e014950. PubMed ID: 32390535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia.
    Miyazaki T; Yamamura Y; Onogawa T; Nakamura S; Kinoshita S; Nakayama S; Fujiki H; Mori T
    Endocrinology; 2005 Jul; 146(7):3037-43. PubMed ID: 15831573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment options for hyponatremia in heart failure.
    Goldsmith SR
    Heart Fail Rev; 2009 Jun; 14(2):65-73. PubMed ID: 18777208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
    Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic dDAVP infusion in rats decreases the expression of P2Y2 receptor in inner medulla and P2Y2 receptor-mediated PGE2 release by IMCD.
    Sun R; Miller RL; Hemmert AC; Zhang P; Shi H; Nelson RD; Kishore BK
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F768-76. PubMed ID: 15914777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
    Robertson GL
    Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults.
    Shoaf SE; Bricmont P; Dandurand A
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1399-1408. PubMed ID: 28803333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue.
    Nishimoto G; Zelenina M; Li D; Yasui M; Aperia A; Nielsen S; Nairn AC
    Am J Physiol; 1999 Feb; 276(2):F254-9. PubMed ID: 9950956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of hyponatremia in cancer patients.
    Castillo JJ; Vincent M; Justice E
    Oncologist; 2012; 17(6):756-65. PubMed ID: 22618570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis.
    Jonassen TE; Nielsen S; Christensen S; Petersen JS
    Am J Physiol; 1998 Aug; 275(2):F216-25. PubMed ID: 9691010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AVP-induced increase in AQP2 and p-AQP2 is blunted in heart failure during cardiac remodeling and is associated with decreased AT1R abundance in rat kidney.
    Lütken SC; Frøkiær J; Nielsen S
    PLoS One; 2015; 10(2):e0116501. PubMed ID: 25658446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney aquaporin-2 expression during escape from antidiuresis is not related to plasma or tissue osmolality.
    Murase T; Ecelbarger CA; Baker EA; Tian Y; Knepper MA; Verbalis JG
    J Am Soc Nephrol; 1999 Oct; 10(10):2067-75. PubMed ID: 10505682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle.
    Nogae S; Michimata M; Kanazawa M; Honda S; Ohta M; Imai Y; Ito S; Matsubara M
    Kidney Int; 2000 May; 57(5):2055-63. PubMed ID: 10792624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An experimental model of syndrome of inappropriate antidiuretic hormone secretion in the rat.
    Verbalis JG
    Am J Physiol; 1984 Oct; 247(4 Pt 1):E540-53. PubMed ID: 6496671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin antagonists: role in the management of hyponatremia.
    Yeates KE; Morton AR
    Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
    Velasco Cano MV; Runkle de la Vega I
    Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of renal salt and water transporters during vasopressin escape.
    Ecelbarger CA; Murase T; Tian Y; Nielsen S; Knepper MA; Verbalis JG
    Prog Brain Res; 2002; 139():75-84. PubMed ID: 12436927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological study of kidney abnormalities in an experimental SIADH rat model and its application to the evaluation of the pharmacologic profile of VP-343, a selective vasopressin V2 receptor antagonist.
    Naito A; Hasegawa H; Kurasawa T; Ohtake Y; Matsukawa H; Ezure Y; Koike K; Shigenobu K
    Biol Pharm Bull; 2001 Aug; 24(8):897-901. PubMed ID: 11510481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.